Phio Pharmaceuticals Corp.
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
PHIO$0.84+4.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. OTHER INFORMATION
| ITEM 9B. | OTHER INFORMATION |
|---|
Trading Plans
During thethree months ended* December 31, 2025*, no director or officer of the Company adopted or terminated a Rule10b5-1 trading arrangement or non-Rule10b5-1 trading arrangement, as each term is defined in Item408(a) of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.